313 related articles for article (PubMed ID: 25604807)
1. Causes of death in men with localized prostate cancer: a nationwide, population-based study.
Van Hemelrijck M; Folkvaljon Y; Adolfsson J; Akre O; Holmberg L; Garmo H; Stattin P
BJU Int; 2016 Mar; 117(3):507-14. PubMed ID: 25604807
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study.
Rider JR; Sandin F; Andrén O; Wiklund P; Hugosson J; Stattin P
Eur Urol; 2013 Jan; 63(1):88-96. PubMed ID: 22902040
[TBL] [Abstract][Full Text] [Related]
3. Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancer.
Crawley D; Garmo H; Rudman S; Stattin P; Zethelius B; Holmberg L; Adolfsson J; Van Hemelrijck M
BJU Int; 2018 Feb; 121(2):209-216. PubMed ID: 28418195
[TBL] [Abstract][Full Text] [Related]
4. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden.
Akre O; Garmo H; Adolfsson J; Lambe M; Bratt O; Stattin P
Eur Urol; 2011 Sep; 60(3):554-63. PubMed ID: 21664039
[TBL] [Abstract][Full Text] [Related]
5. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study.
Stattin P; Sandin F; Thomsen FB; Garmo H; Robinson D; Lissbrant IF; Jonsson H; Bratt O
Eur Urol; 2017 Jul; 72(1):125-134. PubMed ID: 27481175
[TBL] [Abstract][Full Text] [Related]
6. Treatment with curative intent and survival in men with high-risk prostate cancer. A population-based study of 11 380 men with serum PSA level 20-100 ng/mL.
Ladjevardi S; Berglund A; Varenhorst E; Bratt O; Widmark A; Sandblom G
BJU Int; 2013 Mar; 111(3):381-8. PubMed ID: 22758210
[TBL] [Abstract][Full Text] [Related]
7. Natural History of Nonmetastatic Prostate Cancer Managed With Watchful Waiting.
Ventimiglia E; Gedeborg R; Styrke J; Robinson D; Stattin P; Garmo H
JAMA Netw Open; 2024 Jun; 7(6):e2414599. PubMed ID: 38833251
[TBL] [Abstract][Full Text] [Related]
8. Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden.
Bill-Axelson A; Garmo H; Lambe M; Bratt O; Adolfsson J; Nyberg U; Steineck G; Stattin P
Eur Urol; 2010 Mar; 57(3):390-5. PubMed ID: 19914773
[TBL] [Abstract][Full Text] [Related]
9. Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden.
Orrason AW; Styrke J; Garmo H; Stattin P
BJU Int; 2023 Apr; 131(4):486-493. PubMed ID: 36088648
[TBL] [Abstract][Full Text] [Related]
10. Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide population-based study.
Tomic K; Ventimiglia E; Robinson D; Häggström C; Lambe M; Stattin P
Int J Cancer; 2018 Jun; 142(12):2478-2484. PubMed ID: 29363113
[TBL] [Abstract][Full Text] [Related]
11. Risk of prostate cancer in relatives of prostate cancer patients in Sweden: A nationwide cohort study.
Xu X; Kharazmi E; Tian Y; Mukama T; Sundquist K; Sundquist J; Brenner H; Fallah M
PLoS Med; 2021 Jun; 18(6):e1003616. PubMed ID: 34061847
[TBL] [Abstract][Full Text] [Related]
12. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis.
Briganti A; Spahn M; Joniau S; Gontero P; Bianchi M; Kneitz B; Chun FK; Sun M; Graefen M; Abdollah F; Marchioro G; Frohenberg D; Giona S; Frea B; Karakiewicz PI; Montorsi F; Van Poppel H; Jeffrey Karnes R;
Eur Urol; 2013 Apr; 63(4):693-701. PubMed ID: 22959192
[TBL] [Abstract][Full Text] [Related]
13. Risk of localized and advanced prostate cancer among immigrants versus native-born Swedish men: a nation-wide population-based study.
Loeb S; Drevin L; Robinson D; Holmberg E; Carlsson S; Lambe M; Stattin P
Cancer Causes Control; 2013 Feb; 24(2):383-90. PubMed ID: 23266834
[TBL] [Abstract][Full Text] [Related]
14. Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patients.
Moltzahn F; Karnes J; Gontero P; Kneitz B; Tombal B; Bader P; Briganti A; Montorsi F; Van Poppel H; Joniau S; Spahn M
Prostate Cancer Prostatic Dis; 2015 Mar; 18(1):31-7. PubMed ID: 25535100
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Relative Survival and Cause-Specific Survival in Men With Prostate Cancer According to Age and Risk Category: A Nationwide, Population-Based Study.
Orrason AW; Garmo H; Styrke J; Dickman PW; Stattin P
Am J Epidemiol; 2021 Oct; 190(10):2053-2063. PubMed ID: 34007984
[TBL] [Abstract][Full Text] [Related]
16. Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate Cancer.
Beckmann K; Garmo H; Adolfsson J; Bosco C; Johansson E; Robinson D; Holmberg L; Stattin P; Van Hemelrijck M
Eur Urol; 2019 Apr; 75(4):676-683. PubMed ID: 30497883
[TBL] [Abstract][Full Text] [Related]
17. Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostat-ectomy. A nationwide population-based study.
Scilipoti P; Liedberg F; Garmo H; Wilberg Orrason A; Stattin P; Westerberg M
Scand J Urol; 2024 May; 59():98-103. PubMed ID: 38738332
[TBL] [Abstract][Full Text] [Related]
18. Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden.
Orrason AW; Westerberg M; Garmo H; Lissbrant IF; Robinson D; Stattin P
BJU Int; 2020 Jul; 126(1):142-151. PubMed ID: 32274889
[TBL] [Abstract][Full Text] [Related]
19. Temporal trends in cause of death among Swedish and US men with prostate cancer.
Epstein MM; Edgren G; Rider JR; Mucci LA; Adami HO
J Natl Cancer Inst; 2012 Sep; 104(17):1335-42. PubMed ID: 22835388
[TBL] [Abstract][Full Text] [Related]
20. Survival Outcomes in Octogenarian and Nonagenarian Patients Treated with First-line Androgen Deprivation Therapy for Organ-confined Prostate Cancer.
Dell'Oglio P; Bishr M; Boehm K; Trudeau V; Larcher A; Tian Z; Sosa J; Moschini M; Saad F; Capitanio U; Briganti A; Graefen M; Montorsi F; Karakiewicz PI
Eur Urol Focus; 2018 Dec; 4(6):834-841. PubMed ID: 28753853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
